These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1003 related articles for article (PubMed ID: 34643306)

  • 1. Development and validation of model for prediction of placental dysfunction-related stillbirth from maternal factors, fetal weight and uterine artery Doppler at mid-gestation.
    Ashoor G; Syngelaki A; Papastefanou I; Nicolaides KH; Akolekar R
    Ultrasound Obstet Gynecol; 2022 Jan; 59(1):61-68. PubMed ID: 34643306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated fetal weight at mid-gestation in prediction of pre-eclampsia in singleton pregnancy.
    Frei L; Wright A; Syngelaki A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2022 Mar; 59(3):335-341. PubMed ID: 34860455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of stillbirth from maternal factors, fetal biometry and uterine artery Doppler at 19-24 weeks.
    Akolekar R; Tokunaka M; Ortega N; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Nov; 48(5):624-630. PubMed ID: 27854387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35-37 weeks' gestation.
    Ciobanu A; Rouvali A; Syngelaki A; Akolekar R; Nicolaides KH
    Am J Obstet Gynecol; 2019 May; 220(5):486.e1-486.e11. PubMed ID: 30707967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-trimester contingent screening for small-for-gestational-age neonate.
    Nowacka U; Papastefanou I; Bouariu A; Syngelaki A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):177-184. PubMed ID: 34214232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of stillbirth from placental growth factor at 19-24 weeks.
    Aupont JE; Akolekar R; Illian A; Neonakis S; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Nov; 48(5):631-635. PubMed ID: 27854395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stratification of pregnancy care based on risk of pre-eclampsia derived from uterine artery Doppler at 19-24 weeks' gestation.
    Litwinska M; Litwinska E; Lisnere K; Syngelaki A; Wright A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Jul; 58(1):67-76. PubMed ID: 33645854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STATIN trial: predictive performance of competing-risks model in screening for pre-eclampsia at 35-37 weeks' gestation.
    Döbert M; Wright A; Varouxaki AN; Mu AC; Syngelaki A; Rehal A; Delgado JL; Akolekar R; Muscettola G; Janga D; Singh M; Martin-Alonso R; Dütemeyer V; De Alvarado M; Atanasova V; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2022 Jan; 59(1):69-75. PubMed ID: 34580947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11-13 weeks' gestation: data from EVENTS trial.
    Benkő Z; Wright A; Rehal A; Cimpoca B; Syngelaki A; Delgado JL; Tsokaki T; De Alvarado M; Vojtassakova D; Malligiannis Ntalianis K; Chaveeva P; Del Campo A; De Ganzo T; Resta C; Atanasova V; Accurti V; Villalain C; Aguilera J; Dojcinovska D; O'Gorman N; Plasencia W; Zingler E; Dutemeyer V; Alvar B; Casanova MC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Feb; 57(2):257-265. PubMed ID: 33142361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):203-9. PubMed ID: 26224608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre-eclampsia at 19-23 weeks' gestation.
    Sapantzoglou I; Wright A; Arozena MG; Campos RV; Charakida M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):75-83. PubMed ID: 33142353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stratification of pregnancy care based on risk of pre-eclampsia derived from biophysical and biochemical markers at 19-24 weeks' gestation.
    Litwinska M; Litwinska E; Astudillo A; Syngelaki A; Wright A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Sep; 58(3):360-368. PubMed ID: 33794058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of impaired placentation at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Ciobanou A; Jabak S; De Castro H; Frei L; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Jul; 54(1):79-86. PubMed ID: 31100188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-stage approach for prediction of small-for-gestational-age neonate and adverse perinatal outcome by routine ultrasound examination at 35-37 weeks' gestation.
    Akolekar R; Panaitescu AM; Ciobanu A; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):484-491. PubMed ID: 31271475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine artery pulsatility index at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):308-15. PubMed ID: 25970847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ophthalmic artery Doppler at 36 weeks' gestation in prediction of pre-eclampsia: validation and update of previous model.
    Mansukhani T; Wright A; Arechvo A; Laich A; Iglesias M; Charakida M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2024 Feb; 63(2):230-236. PubMed ID: 37616530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different methods of first-trimester screening for preterm pre-eclampsia: cohort study.
    Cuenca-Gómez D; De Paco Matallana C; Rolle V; Mendoza M; Valiño N; Revello R; Adiego B; Casanova MC; Molina FS; Delgado JL; Wright A; Figueras F; Nicolaides KH; Santacruz B; Gil MM
    Ultrasound Obstet Gynecol; 2024 Jul; 64(1):57-64. PubMed ID: 38411276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China.
    Hu J; Gao J; Liu J; Meng H; Hao N; Song Y; Ma L; Luo W; Sun J; Gao W; Meng W; Sun Y
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):529-539. PubMed ID: 33817865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.